HLB Life Science R&D Launches Minor Cannabinoid Drug Development in Fifth State Project
3h ago
Source
Seoul Economic DailyHLB Life Science R&D Launches Minor Cannabinoid Drug Development in Fifth State Projectsedaily.comHLB Life Science R&D was selected as a joint participant in the Gyeongbuk Industrial Hemp Regulatory Free Zone, launching minor cannabinoid drug development with 29.6 billion won over four years.
You might also wanna read
Salk Institute Study Finds Cannabinoids May Help Remove Alzheimer's-Related Proteins from Brain Cells
Salk Institute researchers have found preliminary evidence that THC and other cannabinoids can promote the cellular removal of amyloid beta
salk.edu·3mo agoChina creates new regulatory pathway to accelerate access to advanced biomedical therapies
China has established a new regulatory "tech track" for advanced therapies like personalized cancer treatments, cell and gene therapies, and
Tennessee Hemp Regulations Ban THCA Smokables, Impacting Local Cannabis Businesses
Tennessee's new hemp regulations have taken effect, banning THCA-containing smokable products like joints, vapes, and flower. Businesses suc
Redirecting
doi.org·9d ago
China's biotech rise: A case study in multiple myeloma drug development
This article examines China's rapid advancement in biotechnology through the lens of a multiple myeloma drug development case study. It disc
Therapeutic Use of Cannabis and Cannabinoids: A Review
jamanetwork.com·6mo ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.